NCT06185335: A Trial of the Safety and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia A
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 50 planned
- Started
- 26 Jul 2023
- Primary completion
- Dec 2025
- Arms
- Cohort 1
- Results
- None posted
- 26 Jul 2023: Trial started
- 29 Dec 2023: Trial registered